November 4, 2016
Suzuken Announces Decision to Use AmerisourceBergen's Cubixx System to Enhance Specialty Drug Distribution in Japan
Nagoya, JPN and Valley Forge, PA. – Suzuken and AmerisourceBergen
today announced an agreement that provides Suzuken with access to AmerisourceBergen’s
Cubixx® inventory solution including radio frequency identification
(RFID) enabled refrigeration units and an integrated cloud-based inventory
management portal.
AmerisourceBergen’s Cubixx solution streamlines logistics management for specialty drugs by providing the functionality needed to monitor variables impacting inventory integrity including temperature monitoring and product traceability, which can be made to comply with various laws and regulations pertaining to pharmaceuticals and RFID technology. As the exclusive recipient of Cubixx technology in Japan, the Suzuken Group will further enhance its own capabilities to create efficiencies in the distribution of specialty drugs in Japan, as well as provide added value to medical institutions, insurance pharmacies, community healthcare providers and patients.
Hiromi Miyata, President and CEO of Suzuken, said, “AmerisourceBergen’s Cubixx technology offers us a groundbreaking tool to further enhance our nationwide logistics capabilities for specialty drugs, enabling us to provide Japanese patients with safer and more efficient access to medications. Through the introduction of Cubixx, the Suzuken Group will redouble its dedication to supporting pharmaceutical manufacturers, medical institutions and insurance pharmacies, as well as community healthcare providers and patients.”
James Frary, President of AmerisourceBergen Specialty Group, said, “We’re excited that Cubixx has the opportunity to support the Suzuken Group’s work to improve medication access in Japan.” He also noted, “This agreement is another demonstration of AmerisourceBergen’s desire and ability to form cooperative relationships that create value and enhance its capabilities as a global leader in the health care field.”
About the Suzuken Group
Established in 1932, the Suzuken Group is one of the largest Japanese pharmaceutical distribution and logistics services companies and is listed on the First Section of the Tokyo Stock Exchange. The Suzuken Group defines its business domain as the “health creator” field. The Group conducts a comprehensive range of businesses related to medical care and health, including not only its core pharmaceutical distribution business, but also the research, development, and manufacture of new medicines, support for pharmaceutical manufacturers, the insurance pharmacy business and the nursing care business.In addition, the Suzuken Group is the only pharmaceutical wholesale company in Japan that has distribution functions (a "medical distribution platform") extending from pharmaceutical manufacturers to distributors, and from the distributors to medical institutions and insurance pharmacies. Additionally, the Suzuken Group’s strengths lie in its ability to provide one-stop solutions to meet increasingly diverse and sophisticated pharmaceutical distribution needs from the perspective of manufacturers, medical institutions, insurance pharmacies, and patients.
With over 2 trillion yen in annual net sales, the Suzuken Group is headquartered in Nagoya, Japan and employs approximately 16,000 people.
For more information, go to http://www.suzuken.co.jp/en/
About AmerisourceBergen
AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health. With over $140 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 19,000 people. AmerisourceBergen is ranked #12 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.
About Radio Frequency Identification (RFID)
RFID is an automatic identification and tracking technology that does not require direct contact, using electromagnetic waves to read information from tag or card media embedded with a chip and small antenna.
About Specialty Drugs
Specialty drugs primarily consist of highly priced pharmaceuticals that require strict distribution management, including anticancer drugs, hemophilia treatments, plasma derivatives, albumin preparations, autoimmune disease treatments, vaccines, and orphan drugs.
This news release is distributed as a joint release of Suzuken Co., Ltd. and AmerisourceBergen.
AmerisourceBergen’s Cubixx solution streamlines logistics management for specialty drugs by providing the functionality needed to monitor variables impacting inventory integrity including temperature monitoring and product traceability, which can be made to comply with various laws and regulations pertaining to pharmaceuticals and RFID technology. As the exclusive recipient of Cubixx technology in Japan, the Suzuken Group will further enhance its own capabilities to create efficiencies in the distribution of specialty drugs in Japan, as well as provide added value to medical institutions, insurance pharmacies, community healthcare providers and patients.
Hiromi Miyata, President and CEO of Suzuken, said, “AmerisourceBergen’s Cubixx technology offers us a groundbreaking tool to further enhance our nationwide logistics capabilities for specialty drugs, enabling us to provide Japanese patients with safer and more efficient access to medications. Through the introduction of Cubixx, the Suzuken Group will redouble its dedication to supporting pharmaceutical manufacturers, medical institutions and insurance pharmacies, as well as community healthcare providers and patients.”
James Frary, President of AmerisourceBergen Specialty Group, said, “We’re excited that Cubixx has the opportunity to support the Suzuken Group’s work to improve medication access in Japan.” He also noted, “This agreement is another demonstration of AmerisourceBergen’s desire and ability to form cooperative relationships that create value and enhance its capabilities as a global leader in the health care field.”
About the Suzuken Group
Established in 1932, the Suzuken Group is one of the largest Japanese pharmaceutical distribution and logistics services companies and is listed on the First Section of the Tokyo Stock Exchange. The Suzuken Group defines its business domain as the “health creator” field. The Group conducts a comprehensive range of businesses related to medical care and health, including not only its core pharmaceutical distribution business, but also the research, development, and manufacture of new medicines, support for pharmaceutical manufacturers, the insurance pharmacy business and the nursing care business.In addition, the Suzuken Group is the only pharmaceutical wholesale company in Japan that has distribution functions (a "medical distribution platform") extending from pharmaceutical manufacturers to distributors, and from the distributors to medical institutions and insurance pharmacies. Additionally, the Suzuken Group’s strengths lie in its ability to provide one-stop solutions to meet increasingly diverse and sophisticated pharmaceutical distribution needs from the perspective of manufacturers, medical institutions, insurance pharmacies, and patients.
With over 2 trillion yen in annual net sales, the Suzuken Group is headquartered in Nagoya, Japan and employs approximately 16,000 people.
For more information, go to http://www.suzuken.co.jp/en/
About AmerisourceBergen
AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health. With over $140 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 19,000 people. AmerisourceBergen is ranked #12 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.
About Radio Frequency Identification (RFID)
RFID is an automatic identification and tracking technology that does not require direct contact, using electromagnetic waves to read information from tag or card media embedded with a chip and small antenna.
About Specialty Drugs
Specialty drugs primarily consist of highly priced pharmaceuticals that require strict distribution management, including anticancer drugs, hemophilia treatments, plasma derivatives, albumin preparations, autoimmune disease treatments, vaccines, and orphan drugs.
This news release is distributed as a joint release of Suzuken Co., Ltd. and AmerisourceBergen.